Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial - Concepedia

Concepedia

Publication | Open Access

Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial

DOI Full Paper Access

42

Citations

22

References

2022

Year

Τheodoros Karampitsakos, Panagiota Tsiri, Matthaios Katsaras, Andreas Katsimpris, Andreas P. Kalogeropoulos, Elli Malakounidou, Eirini Zarkadi, Georgios Tsirikos, Vasiliki V. Georgiopoulou, Vasilina Sotiropoulou,

Clinical Microbiology and Infection

Open LabelTocilizumab Versus BaricitinibClinical Infectious DiseaseCovid-19 PandemicClinical TrialsPharmacotherapyCovid-19 EpidemiologyHospitalized PatientsMedicineCovid-19

References

	Year	Citations

Page 1

Page 1